Equities

Extrawell Pharmaceutical Holdings Ltd

Extrawell Pharmaceutical Holdings Ltd

Actions
  • Price (HKD)0.036
  • Today's Change0.001 / 2.86%
  • Shares traded840.00k
  • 1 Year change-28.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments94104114
Total Receivables, Net534744
Total Inventory7.273.028.47
Prepaid expenses1.132.541.40
Other current assets, total222127
Total current assets177179194
Property, plant & equipment, net126137148
Goodwill, net1.811.811.81
Intangibles, net000
Long term investments9771,113958
Note receivable - long term4.611515
Other long term assets------
Total assets1,2871,4451,317
LIABILITIES
Accounts payable4.666.636.46
Accrued expenses9.401013
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.381.322.19
Other current liabilities, total363943
Total current liabilities515764
Total long term debt11910283
Total debt12010385
Deferred income tax------
Minority interest(0.51)(0.15)(0.73)
Other liabilities, total4.174.385.00
Total liabilities174163151
SHAREHOLDERS EQUITY
Common stock242424
Additional paid-in capital192192192
Retained earnings (accumulated deficit)450616487
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total448450463
Total equity1,1131,2821,166
Total liabilities & shareholders' equity1,2871,4451,317
Total common shares outstanding2,3902,3902,390
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.